EW news, real time EW stock news, Edwards Lifesciences Corp news today

News

71.53

-1.24%

-0.90

Insider Sale: CVP of $EW (EW) Sells 1,750 Shares

Barchart · 21h ago

Benjamin Graham Detailed Fundamental Analysis - EW

NASDAQ · 1d ago

Columbia Select Large Cap Equity Fund Q3 2024 Commentary

Seeking Alpha · 1d ago

Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

PR Newswire · 1d ago

Edwards Lifesciences: Balancing Optimism and Caution with a Hold Rating Amidst TAVR Uncertainties

TipRanks · 1d ago

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit

PR Newswire · 1d ago

Oppenheimer Remains a Buy on Edwards Lifesciences (EW)

TipRanks · 2d ago

Truist Financial Gives a Hold Rating to Edwards Lifesciences (EW)

TipRanks · 2d ago

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Context Therapeutics (CNTX) and Xenetic Biosciences (XBIO)

TipRanks · 2d ago

Edwards Lifesciences (EW) Receives a Buy from RBC Capital

TipRanks · 2d ago

Bank of America Securities Keeps Their Hold Rating on Edwards Lifesciences (EW)

TipRanks · 2d ago

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Biogen (BIIB) and Edwards Lifesciences (EW)

TipRanks · 2d ago

TD Cowen Sticks to Its Hold Rating for Edwards Lifesciences (EW)

TipRanks · 2d ago

Edwards Lifesciences: Hold Rating Amidst Transitional Growth Prospects and Market Challenges

TipRanks · 2d ago

Edwards Lifesciences Is Maintained at Buy by Goldman Sachs

Dow Jones · 2d ago

Edwards Lifesciences Price Target Raised to $90.00/Share From $81.00 by Goldman Sachs

Dow Jones · 2d ago

Edwards Lifesciences Poised for Growth with Strategic Initiatives and Robust Financial Outlook

TipRanks · 2d ago

Balanced Outlook with Strategic Potential: A Hold Rating for Edwards Lifesciences

TipRanks · 2d ago

Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $90

Benzinga · 2d ago

Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), Edwards Lifesciences (EW) and Nuvalent (NUVL)

TipRanks · 2d ago

Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.

About EW

Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.